Dr. Reddy's Laboratories Limited (RDY)
Healthcare
$12.22+0.33%Close
BUYRECOVERY · day 15
$12.22+0.33%
Key stats
- Market cap
- $10.2B
- Avg volume
- 2.7M
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
RDY SHAREHOLDER ALERT: Dr. Reddy's Laboratories Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
RDY SHAREHOLDER ALERT: Dr. Reddy's Laboratories Investors Encouraged to Contact Kirby McInerney LLP About Potential Securities Laws Violations
Arrowstreet Capital Limited Partnership Buys Shares of 102,643 Dr. Reddy’s Laboratories Ltd $RDY
Dr. Reddy's Announces the First-to-Market Launch of Sugammadex Injection 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials, a Generic Equivalent of Bridion®, in the United States
Dr. Reddy's Laboratories (RDY) Securities Investigation Notice - Levi & Korsinsky
Dr. Reddy's Laboratories (RDY) Securities Investigation Notice - Levi & Korsinsky
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Dr. Reddy's Laboratories (RDY)
Dr. Reddy's Laboratories Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Dr. Reddy's Laboratories (RDY)
U.S. pharma tariffs 'can't be absorbed' and drug prices will increase, says Dr Reddy's CEO
U.S. to see higher generic drug prices thanks to tariffs, CEO of leading India pharma firm warns
Dr Reddy's Laboratories Ltd (RDY) Shares Surge 3.7% -- What GF Score of 83 Tells Investors
Dr. Reddy's Q1 Earnings and Revenues Miss Estimates, Stock Down
Dr. Reddy's Laboratories Limited (RDY) Q1 2027 Earnings Call Transcript
